Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6273139

C[N+](C)(C)CCNc1ccc(Cl)cc1N.[Cl-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.39
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
ALOX15 P16050 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PRSS1 P07477 8/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
GLA P06280 1/20 0.38
TP53 P04637 1/20 0.37
HDAC1 Q13547 1/20 0.37
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
GFER P55789 1/20 0.36
PLEC Q15149 1/20 0.36
CYP1A2 P05177 1/20 0.36
FERMT2 Q96AC1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2929676 0.98 CYP3A4 (0.40) CYP3A4ALDH1A1TSHRALOX15SMN1; SMN2
Hydrochloric Acid SCHEMBL6268852 0.87 HSD17B2 (0.40) CYP3A4ALDH1A1TSHRALOX15SMN1; SMN2
SCHEMBL2929927 0.85 HSD17B2 (0.40) CYP3A4ALDH1A1TSHRALOX15SMN1; SMN2
Hydrochloric Acid SCHEMBL7638960 0.82 HDAC6 (0.54) CYP3A4ALDH1A1ALOX15SMN1; SMN2TDP1
SCHEMBL15546688 0.81 PRSS1 (0.41) ALDH1A1PRSS1KDM4EGAAMAPT
SCHEMBL2930258 0.80 HDAC6 (0.55) CYP3A4ALDH1A1ALOX15SMN1; SMN2TDP1
SCHEMBL3787955 0.79 ALDH1A1 (0.54) CYP3A4ALDH1A1TSHRALOX15SMN1; SMN2
Hydrochloric Acid SCHEMBL5480784 0.76 MAPT (0.42) ALDH1A1TSHRALOX15SMN1; SMN2TDP1
SCHEMBL419643 0.76 PRSS1 (0.46) CYP3A4ALDH1A1TSHRALOX15SMN1; SMN2
SCHEMBL15595337 0.75 PTGER4 (0.60) CYP3A4ALDH1A1TSHRALOX15SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1334713-B1 Dyeing composition comprising diaminopyrazole and cationic compounds as oxidation bases and a coupling agent OREAL (FR) 2005-12-07 EP claimed
US-6905522-B2 Dye composition comprising an oxidation base of the diaminopyrazole type, a cationic oxidation base and a coupler L'OREAL S.A. (FR) 2005-06-14 US claimed
US-20050097681-A9 DYE COMPOSITION COMPRISING AN OXIDATION BASE OF THE DIAMINOPYRAZOLE TYPE, A CATIONIC OXIDATION BASE AND A COUPLER L'OREAL S.A. (FR) 2005-05-12 US claimed
US-20040045100-A1 Dye composition comprising an oxidation base of the diaminopyrazole type, a cationic oxidation base and a coupler KRAVTCHENKO SYLVAIN (FR) 2004-03-11 US claimed
US-6458168-B1 Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative L'OREAL S.A. (FR) 2002-10-01 US claimed
US-6905522-B2 Dye composition comprising an oxidation base of the diaminopyrazole type, a cationic oxidation base and a coupler L'OREAL S.A. (FR) 2005-06-14 US disclosed
US-20050097681-A9 DYE COMPOSITION COMPRISING AN OXIDATION BASE OF THE DIAMINOPYRAZOLE TYPE, A CATIONIC OXIDATION BASE AND A COUPLER L'OREAL S.A. (FR) 2005-05-12 US disclosed
US-20040045100-A1 Dye composition comprising an oxidation base of the diaminopyrazole type, a cationic oxidation base and a coupler KRAVTCHENKO SYLVAIN (FR) 2004-03-11 US disclosed
US-6458168-B1 Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative L'OREAL S.A. (FR) 2002-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050097681-A9 DYE COMPOSITION COMPRISING AN OXIDATION BASE OF THE DIAMINOPYRAZOLE TYPE, A CATIONIC OXIDATION BASE AND A COUPLER KRT18, AOC1, CYB5R3 CYP3A4 1345/4885ALDH1A1 316/4885TSHR 4242/4885
US-20040045100-A1 Dye composition comprising an oxidation base of the diaminopyrazole type, a cationic oxidation base and a coupler KRT18, AOC1, CYB5R3 CYP3A4 1345/4885ALDH1A1 316/4885TSHR 4242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.